Fluorescence and Single Nanoparticle Sensing Platforms Kadir Aslan,† Meng Wu,‡,§ Joseph R. Lakowicz,‡ and Chris D. Geddes*,†,‡ Institute of Fluorescence, Laboratory for AdVanced Medical Plasmonics, Medical Biotechnology Center, UniVersity of Maryland Biotechnology Institute and Center for Fluorescence Spectroscopy, UniVersity of Maryland School of Medicine, 725 West Lombard Street, Baltimore, M...

Ahmed Abdel-Latif1, Ewa Zuba-Surma2 and Mariusz Z. Ratajczak3 1Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, and Lexington VA Medical Center, Lexington, KY 2Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, 3Stem Cell Biology Institute, James Graham Brown Cancer Center, University ...

Authors’ Affiliations: School of Life Sciences and Biotechnology, Korea University; National Research Laboratory of Animal Cell Biotechnology, School of Agricultural Biotechnology, Seoul National University;Department of Otorhinolaryngology-Head and Neck Surgery, Konkuk University School of Medicine; Department of Neurosurgery, Samsung Medical Center and Samsung Biomedical Research Institute, S...

The rapid progress of modern biotechnology has presented a number of new and unique ethical and social challenges within the context of human medical science. Research in medical biotechnology has led to increased knowledge of disease, acceleration of the treatment process, improved pharmacotherapy for infectious diseases and hope for the struggle against incurable diseases such as ALS, MS and ...

The biotechnology industry has grown rapidly in recent years, doubling in size between 2004 and 2014. Much attention is given to the potential of the biotechnology industry, from drugs and environmental products currently in the pipeline. These products have the potential to generate tremendous opportunities for society, by improving the quality of health care and producing a cleaner environmen...

The main thrust was in the development of diagnostic assays or kits, either for import substitution or to meet diagnostic needs for diseases of importance, Emphasis was on the development of diagnostic probes either using the hybridoma technology for the production of monoclonal antibodies (MABs) or the development of nucleic acid probes, In other instances, more conventional techniques for the...

Evidence Based Medicine (EBM) can be found as far back as the 1940s. However, it was in 1972 that the concept first came into play, originated by Professor Archie Cochrane, in his book, Effectiveness & Efficiency: Random Reflections on Health Services. This was the foundation for evidence based research, and in 1992 a facility was funded by the UK government, with the aim of performing randomly...